Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and HD-ASCT for CNS Relapse of Aggressive Lymphomas
NCT01148173Phase 2Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2007
- Primary completion
- Oct 2011
- Modality
- Targeted Liposomes, Orthosteric Ligands, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, ifosfamide, cytarabine, thiotepa, liposomal cytarabine in non-Hodgkin lymphoma (NHL), sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
methotrexateifosfamidecytarabinethiotepaliposomal cytarabine
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01148173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148173.